Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream
- 31 October 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 51 (4) , 639-642
- https://doi.org/10.1016/j.jaad.2004.04.022
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Topically Applied Imiquimod Inhibits Vascular Tumor Growth In VivoJournal of Investigative Dermatology, 2003
- Hemangiomas of infancyJournal of the American Academy of Dermatology, 2003
- Infantile HemangiomaArchives of Dermatology, 2002
- Imiquimod 5% cream: a topical immune response modifierInternational Journal of Dermatology, 2002
- Imiquimod stimulates innate and cell mediated immunity which controls virus infections and tumorsInternational Journal of Dermatology, 2002
- Imiquimod: An immune response modifierJournal of the American Academy of Dermatology, 2000
- Immunomodulatory and pharmacologic properties of imiquimodJournal of the American Academy of Dermatology, 2000
- Imiquimod, a Topical Immune Response Modifier, Induces Migration of Langerhans Cells11The authors have declared a conflict of interest.Journal of Investigative Dermatology, 2000
- Toxicity profile of interferon alfa-2b in children: A prospective evaluationThe Journal of Pediatrics, 1999
- Successful Treatment of Infantile Hemangiomas with Interferon-α-2bJournal of Pediatric Hematology/Oncology, 1997